agilon health, inc.
AGL
$96.58
$3.854.15%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.49B | 1.42B | 1.57B | 1.43B | 1.39B |
| Total Other Revenue | 1.82M | 1.91M | 2.51M | 2.88M | 2.94M |
| Total Revenue | 1.49B | 1.42B | 1.57B | 1.44B | 1.39B |
| Cost of Revenue | 1.39B | 1.36B | 1.66B | 1.50B | 1.45B |
| Gross Profit | 107.14M | 65.02M | -90.67M | -67.65M | -52.43M |
| SG&A Expenses | 80.87M | 48.12M | 58.76M | 52.11M | 56.16M |
| Depreciation & Amortization | 6.86M | 6.79M | 6.97M | 7.43M | 7.32M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.48B | 1.41B | 1.73B | 1.56B | 1.51B |
| Operating Income | 19.41M | 10.11M | -156.40M | -127.18M | -115.91M |
| Income Before Tax | 17.58M | 29.94M | -187.56M | -110.54M | -104.31M |
| Income Tax Expenses | -375.00K | 28.00K | 1.32M | -331.00K | 62.00K |
| Earnings from Continuing Operations | 17.96M | 29.92M | -188.88M | -110.21M | -104.37M |
| Earnings from Discontinued Operations | -- | 19.00M | 0.00 | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.96M | 48.92M | -188.88M | -110.21M | -104.37M |
| EBIT | 19.41M | 10.11M | -156.40M | -127.18M | -115.91M |
| EBITDA | 26.27M | 16.90M | -152.68M | -119.75M | -108.59M |
| EPS Basic | 1.07 | 2.95 | -11.39 | -6.65 | -6.31 |
| Normalized Basic EPS | 0.94 | 1.36 | -5.66 | -4.01 | -3.93 |
| EPS Diluted | 1.04 | 2.94 | -11.39 | -6.65 | -6.31 |
| Normalized Diluted EPS | 0.92 | 1.35 | -5.66 | -4.01 | -3.93 |
| Average Basic Shares Outstanding | 16.71M | 16.60M | 16.58M | 16.58M | 16.55M |
| Average Diluted Shares Outstanding | 17.21M | 16.66M | 16.58M | 16.58M | 16.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |